Leerink Partners analyst Marc Goodman is defending Allergen (NYSE: AGN) after the company suspended their ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE